• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童炎症性肠病的医学管理

Medical management of pediatric inflammatory bowel disease.

作者信息

Baldwin Katherine R, Kaplan Jess L

机构信息

Pediatric Gastroenterology and Nutrition, MassGeneral Hospital for Children, Harvard Medical School, Boston, MA.

Pediatric Gastroenterology and Nutrition, MassGeneral Hospital for Children, Harvard Medical School, Boston, MA.

出版信息

Semin Pediatr Surg. 2017 Dec;26(6):360-366. doi: 10.1053/j.sempedsurg.2017.10.005. Epub 2017 Oct 5.

DOI:10.1053/j.sempedsurg.2017.10.005
PMID:29126504
Abstract

Inflammatory bowel diseases (IBD) are chronic autoimmune conditions of the gut affecting both pediatric and adult patients. Medical therapy is often successful at inducing and maintaining remission and preventing disease complications. The mainstays of treatment are medications and other therapies that reduce inflammation and suppress the overactive immune system. Here we review current medical therapies for pediatric IBD, discuss future therapeutics, and present current treatment goals and approaches.

摘要

炎症性肠病(IBD)是一种影响儿童和成人患者的肠道慢性自身免疫性疾病。药物治疗通常能成功诱导和维持缓解,并预防疾病并发症。治疗的主要手段是使用药物和其他疗法来减轻炎症并抑制过度活跃的免疫系统。在此,我们综述了目前用于儿童IBD的药物治疗方法,讨论了未来的治疗手段,并介绍了当前的治疗目标和方法。

相似文献

1
Medical management of pediatric inflammatory bowel disease.儿童炎症性肠病的医学管理
Semin Pediatr Surg. 2017 Dec;26(6):360-366. doi: 10.1053/j.sempedsurg.2017.10.005. Epub 2017 Oct 5.
2
Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.溃疡性结肠炎和克罗恩病女性的分娩结局以及抗炎药物治疗的药物流行病学方面
Dan Med Bull. 2011 Dec;58(12):B4360.
3
Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.儿童炎症性肠病的免疫抑制治疗:北美儿科胃肠病学与营养学会的一项调查结果。儿科炎症性肠病协作研究论坛免疫抑制应用小组委员会。
Am J Gastroenterol. 1993 Jan;88(1):44-8.
4
Classical and recent advances in the treatment of inflammatory bowel diseases.炎症性肠病治疗的经典进展与最新进展
Braz J Med Biol Res. 2015 Feb;48(2):96-107. doi: 10.1590/1414-431X20143774. Epub 2014 Nov 28.
5
Advances in inflammatory bowel diseases in children.儿童炎症性肠病的进展
Minerva Pediatr. 2012 Jun;64(3):257-70.
6
Treatment of inflammatory bowel disease (IBD).炎症性肠病(IBD)的治疗。
Pharmacol Rep. 2011;63(3):629-42. doi: 10.1016/s1734-1140(11)70575-8.
7
[Chronic inflammatory bowel disease: Crohn's disease and ulcerative colitis].[慢性炎症性肠病:克罗恩病和溃疡性结肠炎]
J Pharm Belg. 2010 Mar(1):1-9.
8
Dietary therapies for adult and pediatric inflammatory bowel disease.成人和儿童炎症性肠病的饮食疗法。
Nutr Clin Pract. 2024 Jun;39(3):530-545. doi: 10.1002/ncp.11146. Epub 2024 Mar 20.
9
Management of acute severe ulcerative colitis in children.儿童急性重症溃疡性结肠炎的管理
Semin Pediatr Surg. 2017 Dec;26(6):367-372. doi: 10.1053/j.sempedsurg.2017.10.006. Epub 2017 Oct 5.
10
[Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].[炎症性肠病(IBD)——病因、发病机制、诊断及治疗的批判性讨论]
Radiologe. 2003 Jan;43(1):1-8. doi: 10.1007/s00117-002-0844-9.

引用本文的文献

1
A systematic review of vedolizumab in treating pediatric ulcerative colitis: efficacy and safety insights.维多珠单抗治疗儿童溃疡性结肠炎的系统评价:疗效与安全性见解
Therap Adv Gastroenterol. 2025 Jul 23;18:17562848251356063. doi: 10.1177/17562848251356063. eCollection 2025.
2
Saffron as a Promising Therapy for Inflammatory Bowel Disease.藏红花作为炎症性肠病的有希望的治疗方法。
Nutrients. 2024 Jul 20;16(14):2353. doi: 10.3390/nu16142353.
3
Treatment of Active Crohn's Disease With Exclusive Enteral Nutrition Diminishes the Immunostimulatory Potential of Fecal Microbial Products.
采用全肠内营养治疗活动期克罗恩病可降低粪便微生物产物的免疫刺激潜能。
Inflamm Bowel Dis. 2024 Dec 5;30(12):2457-2466. doi: 10.1093/ibd/izae124.
4
Efficacy and safety of vedolizumab for pediatrics with inflammatory bowel disease: a systematic review.维得利珠单抗治疗儿童炎症性肠病的疗效和安全性:系统评价。
BMC Pediatr. 2022 Apr 4;22(1):175. doi: 10.1186/s12887-022-03229-x.
5
Efficacy and Safety of Infliximab in Pediatric Crohn Disease: A Systematic Review and Meta-Analysis.英夫利昔单抗治疗儿童克罗恩病的疗效与安全性:一项系统评价和荟萃分析
Can J Hosp Pharm. 2019 May-Jun;72(3):227-238. Epub 2018 Jun 30.
6
Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn's Disease.脆弱拟杆菌可改善克罗恩病临床前模型中的结肠炎症。
Inflamm Bowel Dis. 2019 Jan 1;25(1):85-96. doi: 10.1093/ibd/izy281.